Accessibility Menu

Grifols(FRA) G0FB

Market Cap€1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€6.50
-0.76%
-0.05Today

Grifols Financials at a Glance

Market Cap

€1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€7.42K

Net Income (TTM)

€540.20

EPS (TTM)

€0.66

P/E Ratio

10.00

Dividend

€0.00

Beta (Volatility)

-0.25 (Low)

Price

€6.50

Volume

0

Open

€6.50

Previous Close

€6.50

Daily Range

€6.50 - €6.50

52-Week Range

€5.95 - €8.55

Estimated Earnings Date

N/A

G0FB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grifols

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Industry

Biotechnology

Employees

25,258

CEO

Nacho Abia Buenache, MBA

G0FB Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

8.44%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

10.00%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

258.22M

Volume

0

Avg. Volume

15.712

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Grifols Performance Analysis

Grifols annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 6,063,967,00022.9%
20232023-12-31EUR 6,591,977,0008.7%
20242024-12-31EUR 7,212,382,0009.4%
20252025-12-31EUR 7,524,000,0004.3%
Grifols annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.3110.4%
20232023-12-31EUR 0.06-79.7%
20242024-12-31EUR 0.23270.1%
20252025-12-31EUR 0.59156.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.87K

+1.0%

Gross Profit

€704.00

+1.0%

Gross Margin

37.57%

+1.0%

Market Cap

€1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.06

N/A

Employees

25,258

N/A

Net Income

€183.00

+1.3%

EBITDA

€436.00

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€9.03K

-5.0%

Total Debt

€8.52K

+1.0%

Accounts Receivable

€785.00

+0.9%

Inventory

€3.49K

+1.0%

Long Term Debt

€8.10K

+1.0%

Short Term Debt

€420.00

+0.8%

Return on Assets

2.27%

+1.6%

Return on Invested Capital

1.44%

+0.8%

Free Cash Flow

€162.23

+1.9%

Operating Cash Flow

€228.90

+1.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About G0FB

What is the current price of Grifols?

Grifols is trading at €6.50 per share.

What is the 52-week range for Grifols?

Over the past 52 weeks, Grifols has traded between €5.95 and €8.55.

How much debt does Grifols have?

As of the most recent reporting period, Grifols reported total debt of €8.52B.

How much cash does Grifols have on hand?

Grifols reported €513.00M in cash and cash equivalents in its most recent financial results.

What is Grifols’s dividend yield?

Grifols does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.